Rebecca Harper on LinkedIn: #researchmatters (2024)

"TRAUMA UNVEILED: An In-Depth Review of Initial Treatment of Polytraumatized Patient"Our latest research delves deep into the critical initial treatment strategies for patients with multiple injuries, emphasizing the importance of the ATLS framework, integration of POCUS (Point-of-care ultrasound), and swift management of sepsis. This work is a testament to the collaborative effort of our dedicated team, aiming to enhance patient outcomes in emergency medical care.This publication reflects not only our commitment to advancing medical knowledge but also the collective wisdom and tireless dedication of healthcare professionals worldwide. I am incredibly proud to contribute to a field that impacts lives at their most vulnerable moments.I want to extend my deepest gratitude to my mentor, Marija Milenkovic MD, PhD, FCCS for making this possible and, further, to every individual who contributed to bringing this remarkable achievement to fruition. Without your unwavering commitment and assistance, this success would not have been possible.Read the full article here: https://lnkd.in/dK2JHVu6Citation: Milenković M, Grošelj BL, Hadzibegović A, Rović I, Šijan D (2024) TRAUMA UNVEILED: An In-Depth Review of Initial Treatment of Polytraumatized Patient. Ann Case Report 9: 1655. DOI: 10.29011/2574-7754.101655

15

Dr. Davide Simonato, a leading Interventional Neuroradiologist, leverages Brainomix 360 Stroke to transform stroke care at Oxford University Hospitals NHS Foundation Trust. “The risk in a spoke hospital of having large vessel occlusion (LVO) patients left behind is real, especially those with equivocating symptoms or fluctuating NIHSS. Brainomix alerts either the Radiologist or Stroke Team about potential LVO patients, to be discussed, that potentially otherwise might not be promptly recognized.”By enhancing communication, speeding up decisionmaking, and striving to ensure no LVO patient is left behind, Brainomix 360 Stroke helps establish a new standard in stroke management. Read more about Davide on our website ⬇:https://lnkd.in/gEXTttBk#HealthcareInnovation #Brainomix360 #NoLVOLeftBehind #TransformingTreatment

55

Leveraging clinically validated AI technology to make proper life-saving decisions: for stroke, this is neither a ´nice-to-have’ nor a threat, this is a ´must-have ‘ and common sense to support our beloved ones!

62

2 Comments

🌟 Featured Session: When to Intubate? 🌟Join us at Mayo Clinic's Innovative Horizons: Transforming Critical Care Medicine 2024, where Dr. Soto Soto, M.D., will lead an essential session on "When to Intubate?" This session will cover critical topics including defining respiratory failure, identifying the need for mechanical ventilation, and understanding intubation pitfalls.📅 Date: August 9-11, 2024📍 Location: Mayo Clinic, Jacksonville, FL🌐 Attendance Options: Live (in-person) and Livestream (virtual)🤝 This groundbreaking event is more than a conference; it’s a multidisciplinary experience where knowledge, practice, education, and research converge. Engage with world experts in critical care, learn from high-fidelity simulations, and be part of a community dedicated to excellence and innovation.🔗 Register now: https://lnkd.in/e6aYuPBJ#CriticalCareMedicine #InnovativeHorizons #MayoClinicEducation #CriticalCareConference #HealthcareInnovation #PatientCare #MedicalEducation #ECMO #SimulationTraining #AcuteCare #InterdisciplinaryCare #CriticalCareResearch #HealthcareCollaboration #CriticalCareNursing Jose Solis Padilla, M.B.A. Sebastián Ugarte Jorge Pascual Charles Burger@CriticalCareMedicine @RespiratoryTherapists @HealthcareProfessionalsNetwork @MedicalEducation @EmergencyMedicine

1

🚨 This Week's Paper of Interest! 🚨Cardiac arrest and resuscitation science is evolving rapidly, with the last decade witnessing a surge in ground breaking randomised clinical trials (RCTs). 🌟This week's highlighted paper delves into the key findings from four pivotal multicentre RCTs published in 2023, highlighting advancements in:Early Initiation of Extracorporeal Life Support in Refractory OHCA (INCEPTION) trialTargeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME)Expedited transfer to a cardiac arrest centre for non-ST elevation OHCA (ARREST)STERoid for Out-of-Hospital Cardiac Arrest (STEROHCA) trialThese studies, selected for their large sample size, multicentre design, and significant clinical outcomes, are shaping the future of resuscitation protocols and patient care. 📈🩺Don’t miss out on these vital insights that can inform your practice and improve patient outcomes. Read the full article now!👉 Read More: [Link in bio]#CardiacArrest #ResuscitationScience #RCTs #MedicalResearch #ClinicalTrials #OHCA #MedicalAdvancements #ImmerseMedical #HealthcareInnovation #LifesavingResearch #StayInformed

1

Revolutionizing Heart Care: Novant Health's Game-Changer for AFib Patients Navigating through the maze of atrial fibrillation (AFib) options, Novant Health has hit a milestone. We've introduced a ground-breaking FDA-approved AFib treatment to our Heart & Vascular Institute - Pulsed Field Ablation (PFA) by Medtronic. What makes PFA a game-changer? It zeroes in on erratic cardiac tissue with precision electrical pulses, paving the way for a corrected heartbeat. But that's not all. Our first successful PFA procedures took place simultaneously at New Hanover Medical Center and Forsyth Medical Center on April 3rd, a move that speaks volumes about our unified dedication to advancing patient care. AFib isn't just about irregular heartbeats - it's a risk multiplier for heart failure and stroke. Our commitment means tackling these risks head-on for the well-being of our community, especially with over 12 million Americans projected to be affected by 2030. As we make strides in heart health, Novant Health is proud to bring next-gen treatments right to the hearts of our patients. #HeartHealth #AFibTreatment #Innovation

1

The #ECMO story became a classic example of translational biomedical research. Rounding daily in the neonatal, pediatric, and adult #ICU maintains a broad perspective on medicine that translates to both patient care and research. If a laboratory experiment or a clinical case works, it can be repeated every time, and others can learn from it. Using artificial organs for life support in fatal heart and lung failure has grown from an idea to standard practice over six decades, as has the entire discipline of critical care medicine: It will be fascinating to see where these aspects of patient care will be 60 yr from now.

67

In our latest blog, Dr. Bret N. Wiechmann discusses how he looks forward to interacting with experts from all disciplines who help manage CLI patients. Read more below & register today to secure your spot at AMP: https://bit.ly/3zIlD2o

8

The latest PEP Health Hospital Rankings shine a spotlight on cardiovascular care.Our patient experience platform ingests millions (and millions) of patient reviews and pieces of feedback, transforming it all into measurable and comparable real-time insights. Leading hospitals and health systems are using these insights to better understand their patients, benchmark variation in care, increase HCAHPS and CMS Star Ratings, provide transparency to unmet needs, and ultimately drive better health outcomes.See how the rankings shake out with PEP Health Hospital Rankings for Best in Cardiology Patient Experience here: https://lnkd.in/gzT3EVdN

8

We are excited to unveil a second set of new data presented at this year’s American Heart Association Scientific Sessions, showing that Cadence’s remote patient monitoring solution yielded meaningful improvements in vitals and adherence to life-saving medications and guidelines amongst patients with heart failure with preserved ejection fraction (HFpEF). In a study of 215 patients with HFpEF, results showed a 12x increase in patients on all four pillars of guideline-directed medical therapy (GDMT), a treatment that saves and improves the quality of lives for patients with heart failure.Dr. Marat Fudim, an advanced heart failure specialist and cardiologist at the Duke University Medical Center and senior author on Cadence’s AHA abstract, shared: “This data demonstrates how RPM can help clinicians titrate and achieve high doses of life-saving GDMT in an effective and timely manner. Cadence’s team of multi-disciplinary heart failure clinicians are leveraging RPM and GDMT protocols to support HFpEF patients achieve better cardiovascular outcomes and quality of life.”Read the full results and abstract here: https://lnkd.in/e8Jcqs7k#aha23

55

1 Comment